Thailand will receive the Covid-19 vaccine developed by British pharmaceutical company AstraZeneca and the University of Oxford as early as mid-2021. The vaccine will be produced locally at the Siam Bioscience Group production plant located in Pathum Thani. The Thai government is working with AstraZeneca and the University of Oxford to produce vaccines at the factory. AstraZeneca chose Siam Bioscience Group as its regional partner in producing vaccines for the Southeast Asian region. National Vaccine Institute (NVI) director Nakhon Premsri told media he was confident the British pharmaceutical company would soon get vaccine approval from the UK's Food and Drug Administration (FDA). "If the vaccine gets approval from the Thai FDA, we will start producing for the public in the middle of next year. We are confident that the vaccine made by AstraZeneca will soon get approval from the UK-based FDA, because it has a high efficacy rate of 70 percent, that's more. of that. H...